New understanding of aggressive form of breast cancer paves the way for tests and treatments
Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to ...
Scoop23 天
New Clinical Trial Launched To Tackle “Elusive” Lobular Breast Cancer
Auckland radiologist Dr Remy Lim is inviting Kiwis who’ve recently been diagnosed with lobular breast cancer to take part in a new clinical trial funded by Breast Cancer Foundation NZ.
Scoop23 天
New Clinical Trial Launched To Tackle “Elusive” Lobular Breast Cancer
Auckland radiologist Dr Remy Lim is inviting Kiwis who’ve recently been diagnosed with lobular breast cancer to take part in a new clinical trial funded by Breast Cancer Foundation NZ. The trial is ...
Comox Valley Record3 天
Genetic testing helps B.C. hereditary cancer survivor break the cycle
Natasha Benn shares family's fight with rare cancer, while geneticists discuss breakthroughs in cancer research ...
Pharmaceutical Technology2 天
Ruxolitinib phosphate by Incyte for Coronavirus Disease 2019 (COVID-19) Associated Cytokine ...
Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.
Pharmaceutical Technology1 天
Ruxolitinib phosphate by Novartis for Coronavirus Disease 2019 (COVID-19): Likelihood of ...
Ruxolitinib phosphate is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19).
Metro24 天
I only had one tiny symptom – I never thought it was cancer
‘What if my scar bursts open, and my implant comes out?’, I thought wildly, as I gingerly climbed down the swimming pool steps and into the water. Of course, that can’t happen, but it all ...